Abstract
A 75-year-old man with a known history of an ischemic cardiomyopathy presents for resection of a presumed malignant liver tumor. He had 2 cardiac stents placed in the last year and a half. His medications include spironolactone, lisinopril, pioglitazone, and atorvastatin. He also takes 81 mg aspirin per day. A recent cardiac catheterization showed that his stents were wide open and there was evidence of diffuse, cardiac arterial disease not amenable to stenting or surgery. His ejection fraction is 32 %, and there is diastolic dysfunction on his echocardiogram.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Luecke T, Roth H, Herrmann P, Joachim A, Weisser G, Pelosi P, Quintel M. Assessment of cardiac preload and left ventricular function under increasing levels of positive end-expiratory pressure. Intensive Care Med. 2004;30(1):119–26.
Sacks FM, Pfeffer MA, Moye LA, Rouleau JL, Rutherford JD, Cole TG, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators. N Engl J Med. 1996;335(14):1001–9.
POISE Study Group, Devereaux PJ, Yang H, Yusuf S, Guyatt G, Leslie K, Villar JC, et al. Effects of extended-release metoprolol succinate in patients undergoing non-cardiac surgery (POISE trial): a randomized controlled trial. Lancet. 2008;371(9627):1839–47.
Edelmann F, Gelbrich G, Duvinage A, Stahrenberg R, Behrens A, Prettin C, et al. Differential interaction of clinical characteristics with key functional parameters in heart failure with preserved ejection fraction—results of the Aldo-DHF trial. Int J Cardiol. 2013;169(6):408–17.
Bulluck H, Fröhlich GM, Mohdnazri S, Gamma RA, Davies JR, Clesham GJ, et al. Mineralocorticoid receptor antagonist pretreatment to MINIMISE reperfusion injury after ST-elevation myocardial infarction (the MINIMISE STEMI Trial): rationale and study design. Clin Cardiol. 2015;38(5):259–66.
McCluskey SA, Karkouti K, Wijeysundera D, Minkovich L, Tait G, Beattie WS. Hyperchloremia after noncardiac surgery is independently associated with increased morbidity and mortality: a propensity-matched cohort study. Anesth Analg. 2013;117(2):412–21.
Perel P, Roberts I, Ker K. Colloids versus crystalloids for fluid resuscitation in critically ill patients. Cochrane Database Syst Rev 2013; 2:CD000567.
Massicotte L, Perrault MA, Denault AY, Klinck JR, Beaulieu D, Roy JD, et al. Effects of phlebotomy and phenylephrine infusion on portal venous pressure and systemic hemodynamics during liver transplantation. Transplantation. 2010;89(8):920–7.
Evans CH, Lee J, Ruhlman MK. Optimal glucose management in the perioperative period. Surg Clin North Am. 2015;95(2):337–54.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this chapter
Cite this chapter
Scher, C.S. (2017). Should Recent Clinical Trials Change Perioperative Management in Patients with Cardiac Risk Factors?. In: Scher, C., Clebone, A., Miller, S., Roccaforte, J., Capan, L. (eds) You’re Wrong, I’m Right. Springer, Cham. https://doi.org/10.1007/978-3-319-43169-7_1
Download citation
DOI: https://doi.org/10.1007/978-3-319-43169-7_1
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-43167-3
Online ISBN: 978-3-319-43169-7
eBook Packages: MedicineMedicine (R0)